The synthesis and chelation chemistry of DOTA-peptide conjugates.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bioconjugate chemistry

• Publication date

  2008-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BC700328SPMID 18072717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds.

  2007cited by this paper
• Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

  2007cited by this paper
• Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.

  2007cited by this paper
• Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.

  2007cited by this paper
• Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2:342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma.

  2007cited by this paper
• Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy.

  2007cited by this paper
• Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3.

  2007cited by this paper
• In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules.

  2007cited by this paper
• Radiolabelled regulatory peptides for imaging and therapy.

  2007cited by this paper
• Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.

  2007cited by this paper
• In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties.

  2007cited by this paper
• Radiolabeled peptides and proteins in cancer therapy.

  2007cited by this paper
• Viral MRI contrast agents: coordination of Gd by native virions and attachment of Gd complexes by azide-alkyne cycloaddition.

  2007cited by this paper
• Peptidyl molecular imaging contrast agents using a new solid-phase peptide synthesis approach.

  2007cited by this paper
• Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes.

  2007cited by this paper
• Development of tissue plasminogen activator specific "on demand cleavable" (odc) linkers for radioimmunotherapy by screening one-bead-one-compound combinatorial peptide libraries.

  2007cited by this paper
• Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

  2007cited by this paper
• Simple synthesis of a building block for solid-phase labeling of oligonucleotides with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA).

  2006cited by this paper
• Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors

  2006cited by this paper
• Antibodies with infinite affinity: origins and applications.

  2006cited by this paper
• Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes

  2006cited by this paper
• Synthetic multivalent ligands as probes of signal transduction.

  2006cited by this paper
• Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting.

  2006cited by this paper
• "Click to chelate": synthesis and installation of metal chelates into biomolecules in a single step.

  2006cited by this paper
• Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.

  2006cited by this paper
• Irreversibly binding anti-metal chelate antibodies: Artificial receptors for pretargeting.

  2006cited by this paper
• Dosimetry in Peptide radionuclide receptor therapy: a review.

  2006cited by this paper
• Site‐Specific Labelling of Proteins with a Rigid Lanthanide‐Binding Tag

  2006cited by this paper
• Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes

  2006cited by this paper
• Equilibrium and formation/dissociation kinetics of some Ln(III)PCTA complexes.

  2006cited by this paper
• Integrins: Molecular targets in cancer therapy

  2006cited by this paper
• Synthesis of Aminooxy‐Functionalized Lanthanide(III) Chelates for Carbonyl‐Group Conjugation

  2006cited by this paper
• In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.

  2006cited by this paper
• microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

  2005cited by this paper
• Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.

  2005cited by this paper
• Radiolabeled peptides in oncology: role in diagnosis and treatment.

  2005cited by this paper
• Conjugation of DOTA using isolated phenolic active esters: the labeling and biodistribution of albumin as blood pool marker.

  2005cited by this paper
• Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.

  2005cited by this paper
• Mass spectral analyses of labile DOTA-NHS and heterogeneity determination of DOTA or DM1 conjugated anti-PSMA antibody for prostate cancer therapy.

  2005cited by this paper
• Integrin alpha v beta 3-targeted imaging of lung cancer.

  2005cited by this paper
• Candidates for peptide receptor radiotherapy today and in the future.

  2005cited by this paper
• Magnetic resonance imaging of self-assembled biomaterial scaffolds.

  2005cited by this paper
• Derivatization of phosphopeptides with mercapto- and amino-functionalized conjugate groups by phosphate elimination and subsequent Michael addition.

  2005cited by this paper
• Solid-phase synthesis of DOTA-peptides.

  2004cited by this paper
• Cellular delivery of MRI contrast agents.

  2004cited by this paper
• Design, synthesis and preclinical evaluation of radiolabeled peptides for diagnosis and therapy.

  2004cited by this paper
• Structural origin of the high affinity of a chemically evolved lanthanide-binding peptide.

  2004cited by this paper
• Irreversible engineering of the multielement-binding antibody 2D12.5 and its complementary ligands.

  2004cited by this paper
• Antibody-targeted radiation cancer therapy

  2004cited by this paper
• Solution dynamics and stability of lanthanide(III) (S)-2-(p-nitrobenzyl)DOTA complexes.

  2004cited by this paper
• Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis.

  2004cited by this paper
• MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.

  2004cited by this paper
• Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.

  2004cited by this paper
• Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

  2004cited by this paper
• Synthesis, characterization, and X-ray crystal structure of In(DOTA-AA) (AA = p-aminoanilide): a model for 111In-labeled DOTA-biomolecule conjugates.

  2003cited by this paper
• Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.

  2003cited by this paper
• Towards the rational design of magnetic resonance imaging contrast agents: isolation of the two coordination isomers of lanthanide DOTA-type complexes.

  2003cited by this paper
• DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

  2003cited by this paper
• Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

  2003cited by this paper
• Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins.

  2003cited by this paper
• Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.

  2003cited by this paper
• Radiolabelled peptides for tumour therapy: current status and future directions

  2003cited by this paper
• Structural variations across the lanthanide series of macrocyclic DOTA complexes: insights into the design of contrast agents for magnetic resonance imaging.

  2003cited by this paper
• Synthesis of target-specific radiolabeled peptides for diagnostic imaging.

  2003cited by this paper
• Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics.

  2002cited by this paper
• Octreotide and Octreotate Derivatives Radiolabeled with Yttrium: Pharmacokinetics in Rats

  2002cited by this paper
• Magnetic resonance imaging detects a specific peptide-protein binding event.

  2002cited by this paper
• Vinyl sulfone bifunctional derivatives of DOTA allow sulfhydryl- or amino-directed coupling to antibodies. Conjugates retain immunoreactivity and have similar biodistributions.

  2002cited by this paper
• Synthesis and evaluation of a monoreactive DOTA derivative for indium‐111‐based residualizing label to estimate protein pharmacokinetics

  2002cited by this paper
• Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

  2002cited by this paper
• Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.

  2001cited by this paper
• Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells.

  2001cited by this paper
• Somatostatin analogs.

  2001cited by this paper
• DOTA tris(phenylmethyl) ester: a new useful synthon for the synthesis of DOTA monoamides containing acid-labile bonds.

  2001cited by this paper
• An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA.

  2001cited by this paper
• (90)Y and (177)Lu labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy.

  2001cited by this paper
• In vivo evaluation of an 111In-labeled ST-peptide analog for specific-targeting of human colon cancers.

  2001cited by this paper
• [Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].

  2001cited by this paper
• Stabilization of (90)y-labeled DOTA-biomolecule conjugates using gentisic acid and ascorbic acid.

  2001cited by this paper
• The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging.

  2000cited by this paper
• Receptor targeting for tumor localisation and therapy with radiopeptides.

  2000cited by this paper
• Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide.

  2000cited by this paper
• Peptides Selected to Bind the Gal80 Repressor Are Potent Transcriptional Activation Domains in Yeast*

  2000cited by this paper
• A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labelling.

  2000cited by this paper
• Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy.

  1999cited by this paper
• Direct solid-phase synthesis of octreotide conjugates: precursors for use as tumor-targeted radiopharmaceuticals.

  1999cited by this paper
• Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

  1999cited by this paper
• Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA).

  1999cited by this paper
• Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1,Tyr3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man.

  1998cited by this paper
• Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.

  1998cited by this paper
• Samarium-153 and lutetium-177 chelation properties of selected macrocyclic and acyclic ligands.

  1998cited by this paper
• Phage Display.

  1997cited by this paper
• Yttrium-90 chelation properties of tetraazatetraacetic acid macrocycles, diethylenetriaminepentaacetic acid analogues, and a novel terpyridine acyclic chelator.

  1995cited by this paper
• A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.

  1994cited by this paper
• Evidence of gadolinium dissociation from protein-DTPA-gadolinium complexes.

  1994cited by this paper
• Large-scale synthesis of the bifunctional chelating agent 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetr aacetic acid, and the determination of its enantiomeric purity by chiral chromatography.

  1992cited by this paper
• Convenient synthesis of bifunctional tetraaza macrocycles.

  1992cited by this paper
• Preparation and characterization of paramagnetic polychelates and their protein conjugates.

  1990cited by this paper
• Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.

  1990cited by this paper
• Gd-DOTA: characterization of a new paramagnetic complex.

  1988cited by this paper

• Glycoconjugates of polyamine metal complexes in cancer diagnosis and therapy

  2025cites this paper
• Towards the Stable Chelation of Radioantimony(V) for Targeted Auger Theranostics.

  2025cites this paper
• Advances in metal-DOTA/DTPA complexes for mass cytometry.

  2025cites this paper
• Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules

  2025cites this paper
• Advances in Rare Earth Metal‐DOTA Complexes for Biomedical Imaging Techniques

  2025cites this paper
• Polymer-Based Mass Cytometry Reagents: Synthesis and Biomedical Applications

  2025cites this paper
• Synthesis of metal-binding amino acids.

  2024cites this paper
• Recent advances in functionalized macrocyclic polyamines for medicine applications

  2024cites this paper
• Fast Barite Scale Dissolution with an 18-Membered Macrocyclic Tetraacetate Ligand─18-py2N4Ac4

  2024cites this paper
• Facile Peptide Macrocyclization and Multifunctionalization via Cyclen Installation

  2024cites this paper
• Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies

  2024cites this paper
• An Upgraded Solid‐Phase Assembly of Chelators (DOTA and NOTA) Enabled Bacterial Uptake Studies of Radiolabeled Peptide

  2024cites this paper
• DIRECT REGULATION OF THE VOLTAGE-SENSING DOMAIN OF HCN CHANNELS BY MEMBRANE LIPID COMPARTMENTALIZATION

  2023influential citation
• Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers

  2023cites this paper
• Microfluidic-based production of [68Ga]Ga-FAPI-46 and [68Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer

  2023cites this paper
• Direct regulation of the voltage sensor of HCN channels by membrane lipid compartmentalization

  2023cites this paper
• Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals.

  2023cites this paper
• N-Benzylethanolammonium Ionic Liquids and Molten Salts in the Synthesis of 68Ga- and Al18F-Labeled Radiopharmaceuticals

  2023cites this paper
• Synthesis of 177Lu-Labeled, Somatostatin-2 Receptor-Targeted Metalla-Assemblies: Challenges in the Design of Supramolecular Radiotherapeutics.

  2023cites this paper
• Facile transmetallation of [SbIII(DOTA)]− renders it unsuitable for medical applications

  2022cites this paper
• Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications

  2022cites this paper
• Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• Preliminary in vitro comparison of 111 In and

  2021cites this paper
• AAZTA: The rise of mesocyclic chelating agents for metal coordination in medicine

  2021cites this paper
• Ten-Membered Rings or Lager With One or More Nitrogen Atoms

  2021cites this paper
• Terbium-functionalized silica nanoparticles for metal ion sensing by fluorescence quenching

  2021cites this paper
• Theoretical Study of Actinide(III)-DOTA Complexes

  2021cites this paper
• DEVELOPMENT AND BIOLOGICAL EVALUATION OF THERANOSTIC NANOSYSTEMS BASED ON NANOCRYSTALLINE CELLULOSE AND LIGNIN NANOPARTICLES

  2021cites this paper
• Affimer-Based Europium Chelates Allow Sensitive Optical Biosensing in a Range of Human Disease Biomarkers

  2021cites this paper
• Iron(IV) complexes with tetraazaadamantane-based ligands: synthesis, structure, applications in dioxygen activation and labeling of biomolecules.

  2021cites this paper
• Capturing an elusive but critical element: Natural protein enables actinium chemistry

  2021cites this paper
• Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma

  2021cites this paper
• Preliminary in vitro comparison of 111In and 131I labeled nimotuzumabs

  2021cites this paper
• Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting

  2021cites this paper
• Solid phase synthesis in the development of magnetic resonance imaging probes

  2020cites this paper
• Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward

  2020cites this paper
• Synthesis of DOTA-pyridine chelates for 64Cu coordination and radiolabeling of αMSH peptide

  2020cites this paper
• Water-Nanomaterial Interaction to Escalate Twin-Mode Magnetic Resonance Imaging.

  2020cites this paper
• Synthesis and properties of Cu- and Pd-complexes of cyclen conjugates with pheophorbide and bacteriopheophorbide

  2020cites this paper
• Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates

  2020cites this paper
• tBu4octapa-alkyl-NHS for metalloradiopeptide preparation.

  2020cites this paper
• Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies

  2020cites this paper
• Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours

  2020cites this paper
• Cerenkov luminescence and PET imaging of 90Y: capabilities and limitations in small animal applications

  2020cites this paper
• Highly specific recognition of denatured collagen by fluorescent peptide probes with the repetitive Gly-Pro-Pro and Gly-Hyp-Hyp sequences.

  2020cites this paper
• Multi-modal imaging probe for assessing the efficiency of stem cell delivery to orthotopic breast tumours

  2020cites this paper
• PET Imaging of a Novel Anxal-targeted Peptide 18 F-Al-NODA-Bn-p-SCN-GGGRDN-IF7 in A431 Cancer Mouse Models.

  2020cites this paper
• The Use of the Macrocyclic Chelator DOTA in Radiochemical Separations

  2020cites this paper
• Synthesis of novel technetium-99m tricarbonyl-HBED-CC complexes and structural prediction in solution by density functional theory calculation

  2019cites this paper
• Radiolabeled Cationic Peptides for Targeted Imaging of Infection

  2019cites this paper
• Evaluating the potential of kit-based 68Ga-ubiquicidin formulation in diagnosis of infection: a pilot study68Ga

  2019cites this paper
• Surface loops of trypsin-like serine proteases as determinants of function.

  2019cites this paper
• A convenient and efficient total solid-phase synthesis of DOTA-functionalized tumor-targeting peptides for PET imaging of cancer

  2019cites this paper
• Clinical aspects of radiolabeled aptamers in diagnostic nuclear medicine: A new class of targeted radiopharmaceuticals.

  2019cites this paper
• Peptides as Radiopharmaceutical Vectors

  2019cites this paper
• Modular Synthesis of DOTA-Metal based PSMA Targeted Imaging Agents for MRI and PET of Prostate Cancer.

  2019cites this paper
• Multi-modal Cell Labelling for Quantification and Optimization of Stem Cell Delivery to Orthotopic Breast Tumors

  2019cites this paper
• MULTIMODALITY SOMATOSTATIN ANALOG FOR FLUORESCENCE-GUIDED SURGERY IN CANCER

  2019cites this paper
• IN VITRO AND IN VIVO EVALUATION OF METAL- CHELATING AGENTS AS NOVEL METALLO BETA-LACTAMASE INHIBITORS AGAINST CARBAPENEM -RESISTANT ENTEROBACTERIACEAE. 2018

  2019cites this paper
• Synthesis of High Relaxivity Gadolinium AAZTA Tetramers as Building Blocks for Bioconjugation.

  2018cites this paper
• MRI Visualization of Injectable Ureidopyrimidinone Hydrogelators by Supramolecular Contrast Agent Labeling

  2018cites this paper
• Cell‐assembled nanoclusters of MSC‐targeting Gd‐DOTA‐peptide as a T2 contrast agent for MRI cell tracking

  2018cites this paper
• Development of a Click-Chemistry Reagent Compatible with Mass Cytometry

  2018cites this paper
• Compatibility between the cysteine-cyclopentenedione reaction and the copper(i)-catalyzed azide-alkyne cycloaddition.

  2018cites this paper
• Improved Efficacy of Synthesizing *MIII-Labeled DOTA Complexes in Binary Mixtures of Water and Organic Solvents. A Combined Radio- and Physicochemical Study.

  2018cites this paper
• Black TiO2-based nanoprobes for T1-weighted MRI-guided photothermal therapy in CD133 high expressed pancreatic cancer stem-like cells.

  2018cites this paper
• Alpha Radionuclide Therapy Using Polymeric Nanocarriers : Solution to the Recoil Problem?

  2018cites this paper
• IR-783 Labeling of a Peptide Receptor for 'Turn-On' Fluorescence Based Sensing.

  2018cites this paper
• Circular Dichroistic Impacts of 1 ‐ ( 3-Dimethylaminopropyl )-3-ethylurea : Secondary Structure Artifacts Arising from Bioconjugation Using 1 ‐ Ethyl-3-[ 3-dimethylaminopropyl ] carbodiimide

  2018cites this paper
• Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for 64Cu-Based PET Imaging.

  2018cites this paper
• Multivalent Siderophore-DOTAM Conjugates as Theranostics for Imaging and Treatment of Bacterial Infections.

  2017cites this paper
• Measurement of reaction kinetics of [177Lu]Lu-DOTA-TATE using a microfluidic system.

  2017cites this paper
• Chelating agents for radiolanthanides: applications to imaging and therapy

  2017cites this paper
• Circular Dichroistic Impacts of 1-(3-Dimethylaminopropyl)-3-ethylurea: Secondary Structure Artifacts Arising from Bioconjugation Using 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide

  2017cites this paper
• Oilfield Scale Removal by Chelating Agents: An Aminopolycarboxylic Acids Review

  2017cites this paper
• Importance of DOTA derivatives in bimodal imaging

  2017cites this paper
• Influence of Dy3+ and Tb3+ doping on 13C dynamic nuclear polarization.

  2017cites this paper
• DFT study of the interaction between DOTA chelator and competitive alkali metal ions.

  2017cites this paper
• Multivalente Siderophor‐DOTAM‐Konjugate als Theranostika zur Visualisierung und Behandlung bakterieller Infektionen

  2017cites this paper
• Molecular Imaging Agent Design for Quantifying Beta Cell Mass in Type 1 Diabetes

  2017cites this paper
• Element labeling of antibody fragments for ICP-MS based immunoassays

  2016cites this paper
• Targeting collagen for diagnostic imaging and therapeutic delivery.

  2016cites this paper
• Improved radiolabeling of DOTATOC with trivalent radiometals for clinical application by addition of ethanol

  2016cites this paper
• MATCHING A CHELATOR (DOTA) WITH IONS FOR RADIO- PHARMACEUTICAL APPLICATIONS USING DFT STUDY

  2016cites this paper
• Bifunctional Gallium-68 Chelators: Past, Present, and Future.

  2016cites this paper
• Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases.

  2016cites this paper
• ¹¹¹In-DOTA-Annexin V for imaging of apoptosis during HSV1-tk/GCV prodrug activation gene therapy in mice with NG4TL4 sarcoma.

  2016cites this paper
• Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design

  2016cites this paper
• The fast method of Cu-porphyrin complex synthesis for potential use in positron emission tomography imaging.

  2016cites this paper
• Radiometallo-Labeled Peptides in Tumor Diagnosis and Targeted Radionuclide Therapy

  2016cites this paper
• Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications.

  2015cites this paper
• Straightforward and mild deprotection methods of N-mono- and N1,N7-functionalised bisaminal cyclens

  2015cites this paper
• Novel approach to radionuclide therapy of cancer: affibody-based bio-orthogonal chemistry mediated pretargeting

  2015cites this paper
• Positron emission tomography imaging using radiolabeled inorganic nanomaterials.

  2015cites this paper
• Peptide Receptor Radionuclide Therapy: An Overview

  2015cites this paper
• Stability analysis of an inline peptide-based conjugate for metal delivery: nickel(II)-claMP Tag epidermal growth factor as a model system.

  2015cites this paper
• Biological evaluation of (177)Lu-labeled DOTA-Ala(SO3H)-Aminooctanoyl-Gln-Trp-Ala-Val-N methyl Gly-His-Statine-Leu-NH2 for gastrin-releasing peptide receptor-positive prostate tumor targeting.

  2015cites this paper
• Affibody Molecules for PET Imaging

  2015cites this paper
• Las dietas mediáticas de los españoles. Estudio a través de los usos del tiempo en 2009-2010

  2015cites this paper
• DOTAM derivatives as active cartilage-targeting drug carriers for the treatment of osteoarthritis.

  2015cites this paper